Literature DB >> 2702908

Reliability of self-monitoring of blood glucose by CSII-treated patients with type I diabetes.

O Ziegler1, M Kolopp, I Got, P Genton, G Debry, P Drouin.   

Abstract

The reliability of patient-generated data from self-monitoring of blood glucose (SMBG) was studied in 14 patients with type I (insulin-dependent) diabetes mellitus treated by continuous subcutaneous insulin infusion (CSII) (7 women, 7 men). The reflectance meters (Glucometer I, Ames, Elkhart, IN) used by the patients were replaced for a period of 21 days by memory-reflectance meters; patients were unaware of the memory capacity of the new meters and were instructed to continue their practice of recording the meter readings in their logbook. This study compares the data recorded in the memory-reflectance meters with those reported in the logbook. The number of SMBG measurements was different in 11 patients (differences ranging from 2 to 66). Mean glycemia was similar (8.23 +/- 0.36 mM in logbook vs. 8.49 +/- 0.48 mM in memory-reflectance meters), but both the M value and mean amplitude of glycemic excursions (MAGE) index were lower when calculated from logbook data (38 +/- 5 vs. 48 +/- 7 mM, P less than .05 and 6.91 +/- 0.43 vs. 7.72 +/- 0.52 mM, respectively; P less than .05). Overreporting (addition of phantom values in logbook) and underreporting (omission of SMBG measurements from logbook) indexes were 19 +/- 7 and 12 +/- 3%, respectively. Precision (percent of identical values in logbook and in memory-reflectance meters at the corresponding time) was 77 +/- 6.8%. The number of SMBG measurements recorded in the memory-reflectance meter was negatively correlated with glycosylated hemoglobin [HbA1c; (r = -.85, P less than .001)], whereas overreporting was positively correlated with HbA1c (r = .76, P less than .01).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2702908     DOI: 10.2337/diacare.12.3.184

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  11 in total

1.  Improved outcomes from diabetes monitoring: the benefits of better adherence, therapy adjustments, patient education, and telemedicine support.

Authors:  David C Klonoff
Journal:  J Diabetes Sci Technol       Date:  2012-05-01

2.  The dilemma of self-monitoring of blood glucose.

Authors:  M B Davidson
Journal:  Diabetologia       Date:  2007-03       Impact factor: 10.122

3.  A focus on blood glucose monitoring: relation to glycemic control and determinants of frequency.

Authors:  Vicki S Helgeson; Erin Honcharuk; Dorothy Becker; Oscar Escobar; Linda Siminerio
Journal:  Pediatr Diabetes       Date:  2011-02       Impact factor: 4.866

4.  Closing the circle of care with new firmware for diabetes: MyDiaBase+RxChecker.

Authors:  A Michael Albisser; Rodolfo Alejandro; Marianne Sperlich; Camillo Ricordi
Journal:  J Diabetes Sci Technol       Date:  2009-05-01

5.  Prescription checking device promises to resolve intractable hypoglycemia.

Authors:  A Michael Albisser; Rodolfo Alejandro; Marianne Sperlich; Camillo Ricordi
Journal:  J Diabetes Sci Technol       Date:  2009-05-01

6.  Can technology improve adherence to long-term therapies?

Authors:  Gérard Reach
Journal:  J Diabetes Sci Technol       Date:  2009-05-01

7.  Development and validation of the Lifestyle Self-Efficacy Scale for Latinos with Diabetes (LSESLD).

Authors:  Monica L Wang; Stephenie C Lemon; Garry Welch; Milagros C Rosal
Journal:  Ethn Dis       Date:  2013       Impact factor: 1.847

Review 8.  Glucose monitoring as a guide to diabetes management. Critical subject review.

Authors:  B Koch
Journal:  Can Fam Physician       Date:  1996-06       Impact factor: 3.275

9.  Ascensia WinGLUCOFACTS Professional Software improves diabetes health outcomes.

Authors:  Michael Janssen; Manuel Portalatin; Jane Wallace; Weiping Zhong; Joan Lee Parkes
Journal:  J Diabetes Sci Technol       Date:  2007-01

Review 10.  Clinical uses of ambulatory blood pressure monitoring.

Authors:  R J Portman; R J Yetman
Journal:  Pediatr Nephrol       Date:  1994-06       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.